The Gross Margin of Neovacs SA (ALNEV.PA) is 5.49%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 5.49% |
2022-12-31 | -51918.92% |
2021-12-31 | -2051.29% |
2020-12-31 | -302.95% |
2019-12-31 | -94950.87% |
2018-12-31 | -6539.58% |
2017-12-31 | -5387.46% |